Post Offer Free
Wuhan Yuancheng Gongchuang Technology Co,ltd
Wuhan Yuancheng Gongchuang Technology Co,ltd

China Sarms Steroids Gefitinib CAS 184475-35-2 for Anticancer Ingredients manufacturer

2nd

Gold Index: 167643

You are here: home  > Pharmaceutical raw material  > Other pharmaceuticals  > Sarms Steroids Gefitinib CAS 184475-35-2 for Anticancer Ingredients

Sarms Steroids Gefitinib CAS 184475-35-2 for Anticancer Ingredients 

Price: 90.0 USD 
Payment Terms: T/T,D/A,WU,Money Gram;Bitcoin 
Place of Origin: Hubei, China (Mainland) 
inquire skype
Add to My Favorites
HiSupplier Escrow
Share |

Product Detail

Means of Transport: Ocean,Air;Express
Packing: disguise package or as requ...
Brand Name: gongchuang
Purity: 99%
source: Gefitinib source
supplier: Gefitinib supplier
Usage: Gefitinib Usage
purity: 99% min
Standard: USP/BP/USP
Production Capacity: 500kg//month
Delivery Date: 4-15days
CAS No.: 184475-35-2
Alias: Gefitinib
usage: Gefitinib usage
price: Gefitinib price
effects: medcine raw
Appearance: powder

Sarms Steroids Gefitinib CAS 184475-35-2 for Anticancer Ingredients;
Pharmaceutical Intermediate Gefitinib (CAS 179688-52-9)
Tyrosine Kinase Inhibit

Selective Inhibitor Gefitinib CAS 184475-35-2 Anticancer Ingredients

Product Name: Gefitinib
Synonyms: IRESSA;GEFITINIB;AKOS 91371;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;ZD 1839;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;Gefitinib(TINIBS)
CAS: 184475-35-2
MF: C22H24ClFN4O3
MW: 446.9
 
Gefitinib Usage
 
Gefitinib is a kind of selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase.
The recommended treatment dose of adult is 250 mg of (1 tablet) with 1 time per day through orally administration, either in empty stomach or together with food.
If you have difficulty in swallowing, you can disperse the tablets into a half cup of drinking water (non-carbonated beverages). Make sure to avoid using other kinds of liquid. Cast tablets into the water and stir until the complete dispersion of the tablet in the water (takes about 10 minutes) without the necessity of crushing. Immediately drink the liquid, and use half glass of water to rinse the cup, drink again. Alternatively, you can also administrate this drug solution through the nose-stomach tube.
There is no necessity in adjusting the administrated dosage of the drug: age, weight, gender, race, renal function, and moderate to severe liver function dysfunction caused by hepatic metastasis.
Dose adjustment: when patients can't tolerate the diarrhea or skin adverse reactions, you can tackle this issue through short-term suspension (up to 14 days) of the treatment and then restore the dose of 250 mg per day.
 
Chemical Properties Light-Yellow Crystalline Powder
Usage Gefitinib (Iressa, ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.
Usage Gefitinib is an antineoplastic.
 
Gefitinib Side effects
 
It has a better tolerability with most adverse reaction being minor and reversible, and is totally different from typical adverse reactions of cytotoxic drug. Common adverse reactions include diarrhea, nausea, rashes, acne, vomiting and weakness with the incidence being over 20%. The ratio of patents who stops the treatment because of the adverse drug reactions is only 1%. Sometimes acute interstitial pneumonia can happen occasionally which can even cause death of some patients. Therefore, if enhanced respiratory symptoms such as shortness of breath, cough and fever happen in the patients, should immediately discontinue the treatment, and find out whether it is interstitial pneumonia. Gefitinib is not suitable for applied to women during pregnancy. Lactation women should stop breastfeeding during the treatment.
 

DMHA / 1,5-Dimethylhexylamine

DMAA / 1,3-Dimethylpentylamine

DMAE bitartrate / 2-Dimethylaminoethanol bitartrate salt

Orlistat
Pregabalin
Isotretinoin
Benzyl benzoate
Benzyl alcohol
Ethyl Oleate
4-Acetamidophenol / Paracetamol
Guaiacol
Tranexamic acid / Amstat
Noopept

Raloxifene hydrochloride
Synephrine hydrochloride
Lorcaserin hydrochloride hemihydrate
Triamcinolone acetonide acetate
Xylazine
Aniracetam
Piracetam
Oxiracetam
Pramiracetam
Fasoracetam
Triclosan
Ibuprofen
Captopril
Adrenosterone / 11-OXO
Androsterone
Pramipexole Hydrochloride

Apremilast (CC-10004) / Otezla

Tyrosine Kinase Inhibitor Gefitinib Raw Powder for Anti-Cancer
Gefitinib

Product Name:Gefitinib
Synonyms:  IRESSA;GEFITINIB;AKOS 91371;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine 
CAS:  184475-35-2
MF:  C22H24ClFN4O3
MW:  446.9
Purity:99.5%
Appearance:White powder
Grade :Pharmaceutical Grade

Usage    Gefitinib is a kind of selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase.

The recommended treatment dose of adult is 250 mg of (1 tablet) with 1 time per day through orally administration, either in empty stomach or together with food. 

If you have difficulty in swallowing, you can disperse the tablets into a half cup of drinking water (non-carbonated beverages). Make sure to avoid using other kinds of liquid. Cast tablets into the water and stir until the complete dispersion of the tablet in the water (takes about 10 minutes) without the necessity of crushing. Immediately drink the liquid, and use half glass of water to rinse the cup, drink again. Alternatively, you can also administrate this drug solution through the nose-stomach tube.

There is no necessity in adjusting the administrated dosage of the drug: age, weight, gender, race, renal function, and moderate to severe liver function dysfunction caused by hepatic metastasis. 

Dose adjustment: when patients can't tolerate the diarrhea or skin adverse reactions, you can tackle this issue through short-term suspension (up to 14 days) of the treatment and then restore the dose of 250 mg per day.


Pharmacokinetic    It is effective through oral administration with a low metabolism rate after the oral absorption. A single oral administration of 250 mg has a bioavailability being close to 60%. During the medication, the area under the curve (AUC) was dose related. After administration of 1 times per day, it reaches steady-state blood drug concentration after the treatment of 7~10 days with the plasma concentration peak occurring at 3~7 hours after the administration, then the blood drug concentration gradually reduces in two phase (half-life: 12~58 hours with average time of 28 hours), and is characterized by dose dependent pharmacokinetic which means that AUC and Cmax increase in proportion to each other with multiple dosing. However, when taking it together with food, its Cmax and AUC did not significantly reduced. It has a plasma protein bind rate being nearly 90%. Gefitinib is metabolized in liver by multiple and complicated metabolic pathways. The enzyme which participates in its oxidative metabolism is mainly the CYP3A4 in the cytochrome P450 enzyme system whose major metabolites are O-dimethyl substance. The metabolites have nothing to do with the pharmacology of the prototype drug. The prototype drug and most of the metabolites are mainly excreted through the biliary drainage and are discharged out of the body through feces. The metabolites excreted through urinary excretion only accounts for lower than 4% of the dosage.

Ms. Gina
skype Ms. Gina
Manager
Tel: 86-27-88211875
Mobile: 188 7222 0799
Contact to this supplier

Didn't find what you're looking for? Post Buying Lead or contact HiSupplier Customer Service Center  for help!

Related Search

Find more related products in following catalogs on Hisupplier.com

Other products from this supplier

Company Info

Wuhan Yuancheng Gongchuang Technology Co,ltd [China (Mainland)]


Business Type:Manufacturer, Trading Company
City: Wuhan
Province/State: Hubei
Country/Region: China (Mainland)

Follow Us: Follow us on facebook Follow us on linkedin Follow us on Twitter

Gina:   skype
Service:   skype

You May Like: